Product Manager, Molecular Diagnostics, Post Transplant
Thermo Fisher ScientificFull Time
Mid-level (3 to 4 years), Senior (5 to 8 years)
Candidates must possess a Bachelor's degree in life science, biology, business, or marketing, or equivalent experience. A minimum of 2 years of direct account management experience in a molecular diagnostics setting with a proven history of exceeding expectations is required, along with 3+ years of experience working with hospital systems. The role demands comfort selling at the executive level, a keen understanding of the payor and reimbursement environment in molecular diagnostics, and strong knowledge of molecular diagnostics in behavioral health and the competitive landscape. Proficiency in Microsoft Office Suite, particularly Excel and PowerPoint, and experience with Salesforce.com are essential. Advanced presentation skills, business acumen, and the ability to work independently with minimal direction are necessary.
The Clinical Account Executive will drive strategic business expansion and collaboration opportunities with major behavioral health clinics, top psychiatry practices, Key Opinion Leaders, and Academic Medical Centers. Responsibilities include structuring strategic plans for client acquisition and retention, collaborating with sales teams to achieve company goals, and identifying partnering opportunities between prospective psychiatrists and Tempus. The role involves promoting and ensuring compliance with new web-based molecular information tools, analyzing the competitive landscape, monitoring sales performance, and developing a comprehensive business plan for the territory. The executive will also work effectively across multiple departments, embrace the Tempus company culture, and maintain a high level of confidentiality.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.